Free Trial

Biorestorative Therapies (BRTX) Competitors

Biorestorative Therapies logo
$1.46 -0.03 (-1.70%)
Closing price 03:57 PM Eastern
Extended Trading
$1.50 +0.04 (+2.42%)
As of 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BRTX vs. BMGL, MRAI, CCM, BGLC, NIVF, MGRX, SSY, DHAC, VSEE, and ACON

Should you be buying Biorestorative Therapies stock or one of its competitors? The main competitors of Biorestorative Therapies include Basel Medical Group (BMGL), Marpai (MRAI), Concord Medical Services (CCM), BioNexus Gene Lab (BGLC), NewGenIvf Group (NIVF), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), VSee Health (VSEE), and Aclarion (ACON). These companies are all part of the "healthcare" industry.

Biorestorative Therapies vs. Its Competitors

Basel Medical Group (NASDAQ:BMGL) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

Basel Medical Group has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. Basel Medical Group's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Basel Medical GroupN/A N/A N/A
Biorestorative Therapies -3,093.61%-129.47%-86.02%

69.4% of Biorestorative Therapies shares are owned by institutional investors. 25.5% of Biorestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Basel Medical Group has higher earnings, but lower revenue than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Basel Medical GroupN/AN/AN/AN/AN/A
Biorestorative Therapies$400K27.46-$8.98M-$1.47-1.00

Biorestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 1,129.00%. Given Biorestorative Therapies' stronger consensus rating and higher possible upside, analysts plainly believe Biorestorative Therapies is more favorable than Basel Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Basel Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biorestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Biorestorative Therapies had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 1 mentions for Biorestorative Therapies and 0 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 0.00 equaled Biorestorative Therapies'average media sentiment score.

Company Overall Sentiment
Basel Medical Group Neutral
Biorestorative Therapies Neutral

Summary

Biorestorative Therapies beats Basel Medical Group on 7 of the 10 factors compared between the two stocks.

Get Biorestorative Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRTX vs. The Competition

MetricBiorestorative TherapiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$11.18M$3.02B$5.57B$9.48B
Dividend YieldN/A2.42%4.31%4.13%
P/E RatioN/A5.8618.7821.62
Price / Sales27.46306.36441.7495.96
Price / CashN/A42.1735.8458.51
Price / Book1.197.818.085.58
Net Income-$8.98M-$54.52M$3.26B$265.35M
7 Day Performance-1.04%-0.87%-0.73%-0.89%
1 Month Performance-7.54%13.63%5.52%4.98%
1 Year Performance6.14%11.57%28.79%23.50%

Biorestorative Therapies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRTX
Biorestorative Therapies
3.0408 of 5 stars
$1.46
-1.7%
$18.00
+1,129.0%
+13.7%$11.18M$400K0.007News Coverage
Upcoming Earnings
BMGL
Basel Medical Group
N/A$2.05
-0.5%
N/AN/A$37.83M$10.00M0.0036
MRAI
Marpai
N/A$1.34
-0.7%
N/A+152.8%$22.33M$34.87M-0.51150News Coverage
Upcoming Earnings
CCM
Concord Medical Services
N/A$5.05
-5.4%
N/A-25.8%$21.92M$52.60M0.00970Gap Up
BGLC
BioNexus Gene Lab
0.211 of 5 stars
$5.73
-13.7%
N/A+31.1%$10.31M$9.51M0.0030Upcoming Earnings
Short Interest ↑
Gap Down
NIVF
NewGenIvf Group
N/A$2.24
-5.1%
N/A-99.7%$9.68M$5.43M0.00N/AGap Down
MGRX
Mangoceuticals
0.9922 of 5 stars
$1.77
+1.1%
N/A-97.8%$9.15M$511.08K-0.383Positive News
Upcoming Earnings
SSY
SunLink Health Systems
1.1369 of 5 stars
$1.02
-8.9%
N/A+19.3%$7.18M$31.09M7.291,376High Trading Volume
DHAC
Digital Health Acquisition
N/A$1.39
+14.9%
N/A-47.9%$5.01MN/A0.002,021High Trading Volume
VSEE
VSee Health
1.3734 of 5 stars
$1.37
-1.4%
$5.00
+265.0%
-48.7%$4.93MN/A0.00N/APositive News
Gap Down
ACON
Aclarion
1.8395 of 5 stars
$7.37
+5.3%
$11,758.50
+159,380.5%
-99.7%$4.29M$54.60K0.007News Coverage
Upcoming Earnings
Gap Up

Related Companies and Tools


This page (NASDAQ:BRTX) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners